hum0200 Release Note

Research IDRelease DateType of Data
hum0200.v6 2024/11/25 NGS (WGS, RNA-seq, EM-seq, t-nanoEM)
hum0200.v5 2022/08/29 NGS (semibulk RNA-seq, scRNA-seq)
hum0200.v4 2022/03/02 NGS (Visium Spatial Gene Expression), Histological image
hum0200.v3 2021/10/01 NGS (Target Capture, Visium Spatial Gene Expression), Histological image
hum0200.v2 2021/05/07 NGS (WGS), Methylation analysis
hum0200.v1 2021/03/29 NGS (Exome), single-cell CNV analysis

 

hum0200.v6

DNAs/RNAs extracted from tumor and non-tumor tissues of a Invasive Ductal Carcinoma (IDC) patient were used for the whole genome sequencing, RNA-seq, EM-seq and t-nanoEM analyses (fastq files).

 

hum0200.v5

Semibulks (cell clumps), prepared from the tumor tissues of Ductal Carcinoma In Situ (DCIS) or Invasive Ductal Carcinoma (IDC), were used for semibulk RNA-seq. Single cells, prepared from the tumor or normal tissues of DCIS and IDC, were used for scRNA-seq. Fastq files are provided.

 

hum0200.v4

RNAs extracted from tumor tissues of a Invasive Ductal Carcinoma (IDC) patient were used for Visium Spatial Gene Expression Assay. Fastq files, tif files (histological image for Visium Spatial Gene Expression Assay) and a tsv file are provided.

 

hum0200.v3

DNAs extracted from tumor tissues of 2 Invasive Ductal Carcinoma (IDC) patients and 72 Ductal Carcinoma In Situ (DCIS) patients were used for the target capture sequencing and RNAs extracted from tumor tissues of 2 IDC patients and a DCIS patient were used for Visium Spatial Gene Expression Assay. Fastq files and tif files (histological image for Visium Spatial Gene Expression Assay) are provided.

 

hum0200.v2

DNAs extracted from tumor and non-tumor tissues of 2 Ductal Carcinoma In Situ (DCIS) patients were used for the whole genome sequencing and DNAs extracted from tumor and non-tumor tissues of 2 Invasive Ductal Carcinoma (IDC) patients and a DCIS patient were used for Methylation analysis. Fastq files and tsv files (CpG methylation calls for 2 patients) are provided.

 

hum0200.v1

DNAs extracted from tumor and non-tumor tissues of 25 Ductal Carcinoma In Situ (DCIS) patients were used for the whole exome sequencing and single-cells from tumor tissues of 2 DCIS patients were used for single-cell CNV analysis (fastq files).

 

Note: